CClinicalTrials.gg
CompletedNCT05629832Updated Mar 18, 2026

Transpulmonary Pressure in Right Ventricle Protection of ARDS

An interventional study of mechanical ventilation strategy guided by transpulmonary pressure in Acute Respiratory Distress Syndrome and Acute Cor Pulmonale, sponsored by Beijing Chao Yang Hospital. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-18.

Sponsored by Beijing Chao Yang Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

To compare the effect between mechanical ventilation strategy guided by transpulmonary pressure and tranditional lung protective ventilation strategy in acute respiratory distress syndrome for right ventricle protection.

02

Conditions studied

  • Acute Respiratory Distress Syndrome
  • Acute Cor Pulmonale
03

In context

Respiratory Distress Syndrome

1,597 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.

This study's enrollment of 40 is below the median of 60 across 961 interventional studies indexed under Respiratory Distress Syndrome.

Browse Respiratory Distress Syndrome studies →

Lead sponsor

Beijing Chao Yang Hospital is the lead sponsor of 135 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • duration of invasive mechanical ventilation less than 72 hours;
  • meet the diagnostic criteria of Berlin definition for ARDS;
  • age older than 18

Exclusion criteria

Exclusion Criteria:

  • esophageal surgery or damage;
  • cardiac surgery;
  • severe bronchopleural fistula;
  • serious arrhythmia; pneumothorax;
  • tricuspid stenosis;
  • heparin allergy;
  • chronic pulmonary heart disease
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    PTP group

    Procedure: mechanical ventilation strategy guided by transpulmonary pressure

  • No intervention
    Control group

Interventions

  • Proceduremechanical ventilation strategy guided by transpulmonary pressure

    Mechanical ventilation parameters adjust guided by transpulmonary pressure monitoring. For pressure assist control or volumn assit control mode; inspiratory pressure or volumn setting needs to maintain Ppeak less than 25 cm H2O; PEEP was set at such a level that expiratory Ptp stayed between 0 and 5 cm H2O.

06

What researchers measure

Primary outcomes

  1. Pulmonary vascular resistance (PVR)

    PVR will measured by Swan-Ganz catheter

    Time frame: 3 days

  2. Pulmonary vascular compliance

    Pulmonary vascular compliance will be calculated using pulmonary artery pressure divided by stroke output measured by Swan-Ganz catheter.

    Time frame: 3 days

07

Study locations

1 site
  • Beijing Chao-Yang Hospital
    Beijing, Beijing Municipality 100020, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05629832
Lead sponsor
Beijing Chao Yang Hospital
Responsible party
Xiao Tang (Doctor, Beijing Chao Yang Hospital) — Principal investigator
First posted
Nov 29, 2022
Start date
Jan 1, 2023
Primary completion
Dec 31, 2024
Completion
Dec 31, 2024
Last update
Mar 18, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion